cytinosis

1 stories · following the connections

Business

Horizon Pharma plc Presents Results from an Open-Label Study on the Use of PROCYSBI® (cysteamine bitartrate) Delayed-Release Capsules in Treatment-Naïve Children Younger than 6 Years of Age

By Nasdaq OMXNov 4, 2017, 3:00 PM UTC